MercadoLibre trades in the green for seven straight sessions
MercadoLibre (NASDAQ:MELI) shares traded in the green on Monday, making it the seventh consecutive day of gains. The stock ...
Mercadolibre’s Strategic Investments and Growth Potential Justify Buy Rating Despite Short-Term Pressures
Analyst Joao Soares from Citi maintained a Buy rating on Mercadolibre (MELI – Research Report) and decreased the price target to $2,450.00 from ...
Brazil antitrust body rules Apple must lift restrictions on in-app payments
Brazilian antitrust regulator Cade said on Monday that Apple must lift restrictions on payment methods for in-app purchases, ...
Techopedia2h
Brazil’s Antitrust Authority Orders Apple to Allow External Payment Methods
Brazil's antitrust regulator, CADE, ordered Apple to lift in-app payment restrictions, following a complaint from ...
Hosted on MSN3h
MercadoLibre price target lowered to $2,450 from $2,480 at Citi
Citi analyst Joao Pedro Soares lowered the firm’s price target on MercadoLibre (MELI) to $2,450 from $2,480 and keeps a Buy rating on the shares.
Brazil's Antitrust Regulator Wants Apple To Remove Restrictions On In-App Payments
According to Reuters, the complaint filed by MercadoLibre in 2022 pointed out that Apple imposes its in-house payment system ...
Apple Faces Daily Fines in Brazil Over App Store Payment Restrictions
Brazil's antitrust regulator has ordered Apple to remove App Store restrictions on third-party payment systems and allow ...
Brazil anti-trust body rules Apple must lift restrictions on in-app payment
Cade ruled that Apple must allow app developers to add tools so customers can buy their services or products outside the app ...
ABP Live on MSN9h
Brazil Gives Apple Deadline Of 20 Days To Lift Restrictions On In-App Payment, Here's What We Know
In 2022, MercadoLibre, filed a complaint accusing Apple of enforcing a series of restrictive practices related to the ...
Brazil demands Apple open up the App Store...or else
More specifically, Apple must take steps such as allowing third-party developers to tell their users about alternative ...
Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.
Amgen stock was dropping in premarket trading, despite positive data from a Phase 2 study for its experimental weight-loss drug, MariTide. The pharmaceutical company said in a statement that after 52 ...
Best Stocks to Buy: Amazon Stock vs. Mercado Libre Stock vs. Shopify Stock
Now that consumer behavior is normalizing, investors are understandably interested in e-commerce stocks. Should you invest $1,000 in Amazon right now? Stock Advisor analyst team just identified what ...